Placenta
Volume 31 , Pages S40-S46 , March 2010

Review: Sex specific programming: A critical role for the renal renin–angiotensin system

  • K.M. Moritz

      Affiliations

    • School of Biomedical Sciences, The University of Queensland, St Lucia 4072, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 7 3365 4598.
    • ,
  • J.S.M. Cuffe

      Affiliations

    • School of Biomedical Sciences, The University of Queensland, St Lucia 4072, Australia
    • ,
  • L.B. Wilson

      Affiliations

    • School of Biomedical Sciences, The University of Queensland, St Lucia 4072, Australia
    • ,
  • H. Dickinson

      Affiliations

    • Department of Physiology, Monash University, Clayton 3800, Australia
    • ,
  • M.E. Wlodek

      Affiliations

    • Department of Physiology, The University of Melbourne, Melbourne 3010, Australia
    • ,
  • D.G. Simmons

      Affiliations

    • School of Biomedical Sciences, The University of Queensland, St Lucia 4072, Australia
    • ,
  • K.M. Denton

      Affiliations

    • Department of Physiology, Monash University, Clayton 3800, Australia

,Accepted 6 January 2010.

References 

  1. Barker DJP. The origins of the developmental origins theory. J Intern Med. 2007;261(5):412–417
  2. Barker DJP, Bagby SP. Developmental antecedents of cardiovascular disease: a historical perspective. J Am Soc Nephrol. 2005;16(9):2537–2544
  3. Mcmillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005;85(2):571–633
  4. Gluckman PD, Hanson MA. The developmental origins of health and disease: an overview. In:  Gluckman PD,  Hanson MA editor. Developmental origins of health and disease. Cambridge: Cambridge University Press; 2006;
  5. Denton KM, Kett MM, Dodic M. Programming hypertension-animal models: causes and mechanisms. In:  Wintour EM,  Owens JA editor. Early life origins of health and disease. New York: Springer Science and Landes Bioscience; 2006;
  6. Moritz KM, Mazzuca MQ, Siebel AL, Mibus A, Arena D, Tare M, et al. Uteroplacental insufficiency causes a nephron deficit, modest renal insufficiency but no hypertension with ageing in female rats. J Physiol. 2009;587(11):2635–2646
  7. Wlodek ME, Mibus A, Tan A, Siebel AL, Owens JA, Moritz KM. Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. J Am Soc Nephrol. 2007;18(6):1688–1696
  8. Zohdi V, Moritz KM, Bubb KJ, Cock ML, Wreford N, Harding R, et al. Nephrogenesis and the renal renin–angiotensin system in fetal sheep: effects of intrauterine growth restriction during late gestation. Am J Physiol Regul Integr Comp Physiol. 2007;293(3):R1267–R1273
  9. Singh RR, Cullen-McEwen LA, Kett MM, Boon W-M, Dowling J, Bertram JF, et al. Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring. J Physiol. 2007;579(2):503–513
  10. Moritz KM, Johnson K, Douglas-Denton R, Wintour EM, Dodic M. Maternal glucocorticoid treatment programs alterations in the renin–angiotensin system of the ovine fetal kidney. Endocrinology. 2002;143(11):4455–4463
  11. Woods LL, Weeks DA. Prenatal programming of adult blood pressure: role of maternal corticosteroids. Am J Physiol Regul Integr Comp Physiol. 2005;289(4):R955–R962
  12. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37(5):1199–1208
  13. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Maternal protein restriction suppresses the newborn renin–angiotensin system and programs adult hypertension in rats. Pediatr Res. 2001;49(4):460–467
  14. Woods LL, Ingelfinger JR, Rasch R. Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Physiol Regul Integr Comp Physiol. 2005;289(4):R1131–R1136
  15. Grigore D, Ojeda NB, Alexander BT. Sex differences in the fetal programming of hypertension. Gend Med. 2008;5(Suppl. 1):S121–S132
  16. Gilbert JS, Nijland MJ. Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul Integr Comp Physiol. 2008;295(6):R1941–R1952
  17. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other?. Am J Hypertens. 1988;1(4 Pt 1):335–347
  18. Coffman TM, Crowley SD. Kidney in hypertension: guyton redux. Hypertension. 2008;51(4):811–816
  19. Hughson M, Farris AB, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003;63(6):2113–2122
  20. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348(2):101–108
  21. Hoy WE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF. Reduced nephron number and glomerulomegaly in Australian aborigines: a group at high risk for renal disease and hypertension. Kidney Int. 2006;70(1):104–110
  22. Moritz KM, Wintour EM, Black MJ, Bertram JF, Caruana G. Factors influencing mammalian kidney development: implications for health in adult life. Adv Anat Embryol Cell Biol. 2008;196:1–78
  23. Ramracheya R, Muller D, Wu Y, Whitehouse B, Huang G, Amiel S, et al. Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia. 2006;49(2):321–331
  24. Ran J, Hirano T, Fukui T, Saito K, Kageyama H, Okada K, et al. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism. 2006;55(4):478–488
  25. Fyhrquist F, Saijonmaa O. Renin–angiotensin system revisited. J Intern Med. 2008;264(3):224–236
  26. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000;87(5):e1–e9
  27. Santos RAS, Ferreira AJ, Silva ACE. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1–7)-Mas axis. Exp Physiol. 2008;93(5):519–527
  28. Schutz S, Le Moullec JM, Corvol P, Gasc JM. Early expression of all the components of the renin–angiotensin-system in human development. Am J Pathol. 1996;149(6):2067–2079
  29. Wintour EM, Alcorn D, Butkus A, Congiu M, Earnest L, Pompolo S, et al. Ontogeny of hormonal and excretory function of the meso- and metanephros in the ovine fetus. Kidney Int. 1996;50(5):1624–1633
  30. Gomez RA, Tufro-McReddie A, Everett AD, Pentz ES. Ontogeny of renin and AT1 receptor in the rat. Pediatr Nephrol. 1993;7(5):635–638
  31. Wolf G, Neilson E. Angiotensin II as a renal growth factor. J Am Soc Nephrol. 1993;3(9):1531–1540
  32. Iosipiv IV, Schroeder M. A role for angiotensin II AT1 receptors in ureteric bud cell branching. Am J Physiol Ren Physiol. 2003;285(2):F199–F207
  33. Wolf G. Angiotensin II and tubular development. Nephrol Dial Transpl. 2002;17(Suppl. 9):48–51
  34. Moritz K, Koukoulas I, Albiston A, Wintour EM. Angiotensin II infusion to the midgestation ovine fetus: effects on the fetal kidney. Am J Physiol Regul Integr Comp Physiol. 2000;279(4):R1290–R1297
  35. Moritz KM, Boon WC, Wintour EM. Aldosterone secretion by the mid-gestation ovine fetus: role of the AT2 receptor. Mol Cell Endocrinol. 1999;157(1–2):153–160
  36. Lumbers ER. Functions of the renin–angiotensin system during development. Clin Exp Pharmacol Physiol. 1995;22(8):499–505
  37. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991;78(1):128–135
  38. Irani RA, Xia Y. The functional role of the renin–angiotensin system in pregnancy and preeclampsia. Placenta. 2008;29(9):763–771
  39. Anton L, Merrill DC, Neves LAA, Diz DI, Corthorn J, Valdes G, et al. The uterine placental bed renin–angiotensin system in normal and preeclamptic pregnancy. Endocrinology. 2009;150(9):4316–4325
  40. Leandro SM, Furukawa LNS, Shimizu MHM, Casarini DE, Seguro AC, Patriarca G, et al. Low birth weight in response to salt restriction during pregnancy is not due to alterations in uterine-placental blood flow or the placental and peripheral renin–angiotensin system. Physiol Behav. 2008;95(1–2):145–151
  41. Benoit C, Gu Y, Zhang Y, Alexander JS, Wang Y. Contractility of placental vascular smooth muscle cells in response to stimuli produced by the placenta: roles of ACE vs. Non-ACE and AT1 vs. AT2 in placental vessel cells. Placenta. 2008;29(6):503–509
  42. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53(3):672–677
  43. Sampson AK, Moritz KM, Jones ES, Flower RL, Widdop RE, Denton KM. Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension. 2008;52(4):666–671
  44. Silva-Antonialli MM, Tostes RCA, Fernandes L, Fior-Chadi DR, Akamine EH, Carvalho MHC, et al. A lower ratio of AT1/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats. Cardiovasc Res. 2004;62(3):587–593
  45. Gilbert JS, Ford SP, Lang AL, Pahl LR, Drumhiller MC, Babcock SA, et al. Nutrient restriction impairs nephrogenesis in a gender-specific manner in the ovine fetus. Pediatr Res. 2007;61(1):42–47
  46. McArdle AM, Denton KM, Maduwegedera D, Moritz K, Flower RL, Roberts CT. Ontogeny of placental structural development and expression of the renin-angiotensin system and 11 beta-HSD2 genes in the rabbit. Placenta. 2009;30(7):590–598
  47. Ichihara A, Kobori H, Nishiyama A, Navar LG. Renal renin–angiotensin system. Contrib Nephrol. 2004;143:117–130
  48. Moritz KM, Singh RR, Probyn ME, Denton KM. Developmental programming of a reduced nephron endowment: more than just a baby's birth weight. Am J Physiol Ren Physiol. 2009;296(1):F1–F9
  49. Wintour EM, Moritz KM, Johnson K, Ricardo S, Samuel CS, Dodic M. Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment. J Physiol. 2003;549(3):929–935
  50. Ortiz LA, Quan A, Weinberg A, Baum M. Effect of prenatal dexamethasone on rat renal development. Kidney Int. 2001;59(5):1663–1669
  51. Dickinson H, Walker DW, Wintour EM, Moritz K. Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R453–R461
  52. Singh RR, Moritz KM, Bertram JF, Cullen-McEwen LA. Effects of dexamethasone exposure on rat metanephric development: in vitro and in vivo studies. Am J Physiol Ren Physiol. 2007;293(2):F548–F554
  53. Wyrwoll CS, Mark PJ, Waddell BJ. Developmental programming of renal glucocorticoid sensitivity and the renin–angiotensin system. Hypertension. 2007;50(3):579–584
  54. Grigore D, Ojeda NB, Robertson EB, Dawson AS, Huffman CA, Bourassa EA, et al. Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring. Am J Physiol Regul Integr Comp Physiol. 2007;293(2):R804–R811
  55. McMullen S, Langley-Evans SC. Maternal low-protein diet in rat pregnancy programs blood pressure through sex-specific mechanisms. Am J Physiol Regul Integr Comp Physiol. 2005;288(1):R85–R90
  56. McMullen S, Langley-Evans SC. Sex-specific effects of prenatal low-protein and carbenoxolone exposure on renal angiotensin receptor expression in rats. Hypertension. 2005;46(6):1374–1380
  57. Cox LA, Nijland MJ, Gilbert JS, Schlabritz-Loutsevitch NE, Hubbard GB, McDonald TJ, et al. Effect of 30 per cent maternal nutrient restriction from 0.16 to 0.5 gestation on fetal baboon kidney gene expression. J Physiol. 2006;572(1):67–85
  58. Vehaskari VM, Stewart T, Lafont D, Soyez C, Seth D, Manning J. Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension. Am J Physiol Ren Physiol. 2004;287(2):F262–F267
  59. Hoppe CC, Evans RG, Bertram JF, Moritz KM. Effects of dietary protein restriction on nephron number in the mouse. Am J Physiol Regul Integr Comp Physiol. 2007;292(5):R1768–R1774
  60. McMullen S, Gardner DS, Langley-Evans SC. Prenatal programming of angiotensin II type 2 receptor expression in the rat. Br J Nutr. 2004;91(1):133–140

PII: S0143-4004(10)00022-6

doi: 10.1016/j.placenta.2010.01.006

Placenta
Volume 31 , Pages S40-S46 , March 2010

Article Tools

* Image Usage & Resolution